The ruling states that federal law does not block the ban on certain cannabinoid products in the state.
On October 11, 2024, Superior Court Judge Stephen I. Goorvitch handed down his decision on the temporary restraining order submitted earlier this month on recent regulations on hemp products in the state of California. The regulations had been in response to increased concerns over minors’ access to the intoxicating products and potential adverse effects. Concerns over the regulations’ effect on businesses had been raised by stakeholders in the industry.
On September 23, 2024, California’s Secretary of State had approved and filed emergency regulations that had been proposed by the state’s Department of Public Health on September 4, 2024. The regulations would require food, beverages and dietary products that contain industrial hemp to have no detectable THC or other intoxicating cannabinoids per serving, limit the number of servings for hemp products to five, and create a minimum age of 21 to purchase hemp products. Subsequently, the US Hemp Roundtable—a coalition of dozens of companies advocating for science-driven hemp laws—along with several farmers and businesses, filed a lawsuit against the regulations.
On October 4, the US Hemp Roundtable had petitioned for a temporary restraining order against California’s emergency hemp regulations to prevent the enforcement of the regulations while the lawsuit is being litigated.
The judge’s decision stated, in part: “This potential harm to Californians, especially children, outweighs the potential that individual hemp businesses will not be able to adapt to the new regulations. At the hearing, Petitioners argued that certain consumers use these products for medicinal purposes. The State’s counsel argued that the record does not support this argument. Regardless, Petitioners’ argument is not persuasive. To the extent that medicinal benefit comes from the hemp plant itself, those products may still be sold in final form (without THC). To the extent the medicinal benefit comes from the THC, consumers can buy THC products in dispensaries, e.g., oil that can be ingested or other THC edibles. For purposes of evaluating irreparable harm, it matters not whether the THC comes from marijuana or hemp plants. It matters only that THC is available to consumers who use it for medicinal purposes. Accordingly, Petitioners cannot demonstrate sufficient irreparable harm for injunctive relief at this stage.”
In an October 14 press release, the US Hemp Roundtable discussed the judge’s ruling. Jonathan Miller, General Counsel for the US Hemp Roundtable, stated, “While we are disappointed with the court’s decision, this is only the first step in what could be a lengthy process. We are currently reviewing all of our options for proceeding. We still hold out hope that Governor Newsom will come to the table and work with industry to achieve our mutual goal – to robustly regulate hemp products and keep them out of the hands of children – without devastating hemp farmers, business and consumers as does his emergency regulation.”
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part II
December 17th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election, including state and federal policies and possible paths forward for testing standardization. Join us in the second part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part I
December 16th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election. We discuss what drives support or opposition from both sides of the aisle, the complexities of balancing state and federal priorities, and more. Join us in the first part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Work Smarter, Not Harder: How ASTM Standards for Cannabinoids Improve Your Operations
December 3rd 2024ASTM Standards D8557-24 and D8556-24, provide unified guidelines for GMP (Good Manufacturing Practices) and QMS (Quality Management Systems) in cannabis operations. These standards enhance compliance, product safety, and operational consistency across the industry for the benefit of operators, consumers, and other stakeholders in the industry.